Leukemia: all 5,475 studies
Page 23 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic LeukemiaWithdrawnNCT05168748Phase 1
- Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05164042Phase 1/2
- Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
- Venetoclax Based Regimen for R/R T-ALLCompletedNCT05149378Phase 2
- Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in LeukemiaCompletedNCT05149339Phase 1/2
- Pneumococcal Vaccination in Patients With Chronic Lymphocytic LeukaemiaStatus unknownNCT05145101
- Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRDStatus unknownNCT05137860Phase 4
- Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT05133310Phase 4
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.Status unknownNCT05127798
- Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction TherapiesStatus unknownNCT05123352
- Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse EventsCompletedNCT05123001
- Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALLWithdrawnNCT05114837Phase 1/2
- PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesTerminatedNCT05107856Phase 1
- Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh NationalityCompletedNCT05095155
- Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic LeukaemiaCompletedNCT05093192Not applicable
- Myeloid Mutations Register in R/R CMLStatus unknownNCT05080829Not applicable
- Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLTerminatedNCT05071482Phase 4
- Belimumab in Patients with Chronic Lymphocytic LeukemiaActive, not recruitingNCT05069051Phase 2
- Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCTStatus unknownNCT05066958Phase 1/2
- Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T TherapyCompletedNCT05064787Not applicable
- A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)Status unknownNCT05061147Phase 1/2
- Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia AdultsStatus unknownNCT05059847Not applicable
- Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival OutcomesCompletedNCT05057299
- Bcl-2 Inhibitors Combined With Azacytidine and Chemotherapy in Elderly Patients With Previously Untreated AMLStatus unknownNCT05053425Not applicable
- Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or DexamethasoneCompletedNCT05049785Early Phase 1
- Pharmacokinetics, Tolerability and Safety of NEX-18aCompletedNCT05048498Phase 1
- Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic LeukemiaCompletedNCT05045443Phase 2
- Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid LeukemiaStatus unknownNCT05042531Not applicable
- XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic LeukemiaTerminatedNCT05038644Phase 1
- Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWithdrawnNCT05037669Phase 1
- Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow CytometerCompletedNCT05035615
- EFFECT OF TREADMILL TRAINING ON BALANCE AFTER CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIACompletedNCT05032716Not applicable
- Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaTerminatedNCT05032599Phase 1
- Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy with Hypomethylating AgentsCompletedNCT05030675Phase 1
- A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALLStatus unknownNCT05026229Not applicable
- A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALLStatus unknownNCT05024357Not applicable
- Application of Nanopore Sequencing in Newly Diagnosed Acute Myeloid Leukemia Patients With Bloodstream InfectionStatus unknownNCT05016752
- Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT05016063Early Phase 1
- Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT05008575Phase 1
- Vaccine Responsiveness in Patients With Chronic Lymphocytic LeukemiaCompletedNCT05007860
- HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALLTerminatedNCT05006040Early Phase 1
- Study of GDX012 in Patients With MRD Positive AMLTerminatedNCT05001451Phase 1
- A Study for Oral SY-2101 for Participants With Acute Promyelocytic LeukemiaSuspendedNCT04996030Phase 1
- Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative NeoplasmCompletedNCT04992949Phase 2
- Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem CellsStatus unknownNCT04991532
- A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT04980885Phase 1/2
- A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter SyndromeTerminatedNCT04978779Phase 1
- SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerActive, not recruitingNCT04977024Phase 2
- Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsCompletedNCT04969601Phase 1/2
- Oral Health Condition and Quality of Life in Children With LeukemiaTerminatedNCT04968860
- Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.CompletedNCT04965649
- Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic LeukemiaCompletedNCT04964908
- Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and LeukemiaWithdrawnNCT04961801Phase 1/2
- Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT04956042Phase 1/2
- B-cell Chronic Lymphoid Malignancies MarkersStatus unknownNCT04952974
- Exercise Training to Promote Resilience to Chronic Lymphocytic LeukemiaCompletedNCT04950452Not applicable
- A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT04946890Phase 1/2
- JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived AsparaginaseApproved for marketingNCT04943952
- Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid MalignanciesCompletedNCT04943757Phase 2
- Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)CompletedNCT04942730Phase 2
- Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage LeukemiaCompletedNCT04938115Not applicable
- The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP PatientsStatus unknownNCT04933526Phase 4
- A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)CompletedNCT04925141Phase 4
- Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)TerminatedNCT04920188
- Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaStatus unknownNCT04916860Not applicable
- Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic SyndromeTerminatedNCT04912063Phase 1
- Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile NeutropeniaCompletedNCT04910698
- Feasibility Pilot Exploring Variability in Biomarkers and PROs in AMLCompletedNCT04908852
- Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 MutationsStatus unknownNCT04906031Phase 2
- HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
- Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.Status unknownNCT04904237Phase 2
- Feasiblity and Safety of Home-based Intensive ChemotherapyCompletedNCT04904211Not applicable
- Physical Fitness Impact of Early Physiotherapy Intervention With a Standardized Exercise Therapy Program in Adult Patients Receiving Intensive Induction Chemotherapy for Treatment of Acute Leukemia During Extended Hospitalization.Status unknownNCT04899882Not applicable
- A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid LeukemiaWithdrawnNCT04896112Phase 1
- Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDSWithdrawnNCT04893915Phase 2
- Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and AdolescentsCompletedNCT04888468Phase 1
- Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALLStatus unknownNCT04888442Phase 1
- A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)CompletedNCT04887857Phase 1
- Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLTerminatedNCT04887259Phase 1
- Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT04886206Phase 1
- Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)Status unknownNCT04884984Phase 1/2
- Value of Using Pioglitazone in Chronic Myeloid Leukemia TreatmentCompletedNCT04883125Phase 2
- Tegavivint for the Treatment of Relapsed or Refractory LeukemiaActive, not recruitingNCT04874480Phase 1
- Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid LeukemiaStatus unknownNCT04867928Phase 2
- Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic SyndromesActive, not recruitingNCT04861207Phase 2
- A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBLWithdrawnNCT04860817Early Phase 1
- Study of Periodontitis and Blood Stream Infection in AML Patients Receiving ChemotherapyTerminatedNCT04858594
- Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT04852822
- Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDSTerminatedNCT04849910Phase 1/2
- Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With ALStatus unknownNCT04846439Phase 1/2
- Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWithdrawnNCT04845035Phase 2
- Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AMLStatus unknownNCT04842370Phase 1
- Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphomaCompletedNCT04840875Phase 1
- Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT04835519Phase 1/2
- A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)CompletedNCT04827069Phase 1
- Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies MalignanciesStatus unknownNCT04823091Phase 1
- TIGIT in Patients With Chronic Myeloid LeukemiaStatus unknownNCT04818619
- Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell TumorsStatus unknownNCT04814004Phase 1
- The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier DamageCompletedNCT04813783